Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

US Patent RE47150 · Granted Dec 4, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Brain natriuretic peptide engrafted antibodies2025
Atrial natriuretic peptide engrafted antibodies2025
Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)2025
Trispecific binding proteins, methods, and uses thereof2025
RNA-programmable endonuclease systems and uses thereof2025
Methods of treatment using CCR8 antibodies2024
Bispecific polypeptide complexes2023
Intron-based universal cloning methods and compositions2023
Site specific homogeneous with KSP inhibitors2023
Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)2023
Trispecific binding proteins, methods, and uses thereof2023
RNA-programmable endonuclease systems and their use in genome editing and other 2023